Create Account | Sign In: Author or Forum

Search Symptoms

Medical Specialty >>

Friday Is the Deadline for Obamacare 2018

7:00 PM CST. By Dennis Thompson
HealthDay Reporter Read article More News

JOURNAL UPDATE

Findings Support Individualized Glycemic Control in T2DM

7:00 PM CST. Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

MONTHLY JOURNAL SUMMARY

November 2017 Briefing - Pharmacy

December 01, 2017. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.


FEATURED ARTICLES

Robert L. Coleman, MD's avatarRucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial

Robert L. Coleman, MD. Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…

Ted Lain, MD's avatarInvestigational Topical Minocycline Gel for Acne Advances to Phase III Development

Ted Lain, MD. Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…

Elizabeth M. Swisher, MD's avatarCharacterization of patients with ovarian carcinoma who respond to the PARP inhibitor rucaparib

Elizabeth M. Swisher, MD. Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity…


MEDICAL FOCUS

Tamer M. Fouad, M.D.'s avatar

Alzheimer’s disease

By Tamer M. Fouad, M.D.

Alzheimer’s disease (AD) is the most common cause of dementia in Western countries.

DISCUSSION

RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development

By MrRobin

Great articles. learnt a lot from it.

ANNOUNCEMENTS

Sunday Times - Doctors Lounge Voted top 10 best ‘Ask an expert’ website

Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.